Transanal Transection and Single-stapled Anastomosis (TTSS) in Rectal Cancer Patients

NCT ID: NCT06314646

Last Updated: 2024-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

472 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-26

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Transanal Transection and Single-Stapled anastomosis (TTSS) technique may be a valid alternative to traditional double-stapled anastomosis for low rectal cancer surgery. This study aims to compare the postoperative and functional outcomes of patients receiving TTSS and traditional double-stapled anastomosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Transanal Transection and Single-Stapled anastomosis (TTSS) technique has become a valid alternative to the standard double-stapled anastomosis approach in the surgical treatment of low rectal cancer. Recent evidence showed a significantly reduced number of anastomotic leaks in patients undergoing TTSS compared with patients receiving double-stapled anastomosis, suggesting that TTSS may be technically feasible and may provide a surgical advantage over the traditional double-stapled technique. However, these studies were severely limited by their single-center and retrospective nature. This study aims to confirm the retrospective findings by extending the data collection to additional countries and provide prospective data collection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectal Cancer Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transanal Transection and Single-Stapled anastomosis (TTSS)

Patients will undergo rectal cancer surgery through low rectal resection with Transanal Transection and Single-Stapled anastomosis (TTSS)

Transanal Transection and Single-Stapled anastomosis (TTSS)

Intervention Type PROCEDURE

Low anterior rectal resection with Transanal Transection and Single-Stapled anastomosis (TTSS)

Double-stapled Total Mesorectal Excision (TME)

Patients will undergo rectal cancer surgery through low rectal resection with double-stapled anastomosis Total Mesorectal Excision (TME)

Double-stapled Total Mesorectal Excision (TME)

Intervention Type PROCEDURE

Low anterior rectal resection with double-stapled Total Mesorectal Excision (TME)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transanal Transection and Single-Stapled anastomosis (TTSS)

Low anterior rectal resection with Transanal Transection and Single-Stapled anastomosis (TTSS)

Intervention Type PROCEDURE

Double-stapled Total Mesorectal Excision (TME)

Low anterior rectal resection with double-stapled Total Mesorectal Excision (TME)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (≥ 18 years old) patients, men and women, diagnosed with rectal cancer scheduled for elective rectal resection with Total Mesorectal Excision (TME) with double-stapled or Transanal Transection and Single-Stapled anastomosis (TTSS) approaches.
* Patients scheduled for open, laparoscopic, or robotic surgery.
* Patients preoperatively indicated for sphincter-saving procedures with or without protective-stoma.

Exclusion Criteria

* Immediate or delayed hand-sewn coloanal anastomosis.
* Patients requiring abdominoperineal resection (APR). Patients undergoing unplanned non-reconstructive surgery will be withdrawn from the study.
* Patients with concurrent or previous invasive pelvic malignant tumors. Patients with an intraoperative evidence of invasive pelvic malignant tumors will be withdrawn from the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istituto Clinico Humanitas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antonino Spinelli, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

IRCCS Huamanitas Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Humanitas Research Hospital

Rozzano, MI, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Annalisa Maroli, PhD

Role: CONTACT

02 8224 7776 ext. 0039

Stefano De Zanet, MS

Role: CONTACT

02 8224 4623 ext. 0039

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Annalisa Maroli, PhD

Role: primary

02 8224 7776 ext. 0039

Stefano De Zanet, MS

Role: backup

02 8224 4623 ext. 0039

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3747

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.